Advair Diskus Once Daily

Links shared publicly online about this topic

Therapeutics Daily

therapeuticsdaily.com — “Therapeutics DailyView full resource at therapeuticsdaily.com

  • View Related
  • Share

Most Recently Shared on August 25, 2009 at 5:39 pm By:

pharmalive PharmaLive Pharma and Health News

Glaxo: 2 Lots of Advair Diskus Stolen From Plant -- http://tinyurl.com/n5k5ou

3 years ago...

Clinical Cases and Images: CasesBlog: Top 10 Most Prescribed Medications

casesblog.blogspot.com — “Health News Updated Daily by an Assistant Professor at University of Chicago, Internist and AllergistView full resource at casesblog.blogspot.com

  • View Related
  • Share

Most Recently Shared on May 19, 2011 at 12:48 pm By:

GSK lung drug has mixed results but filing on track - Yahoo! News

news.yahoo.com — “From Yahoo! News: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday. The new once-a-day inhaled medicine showed superiority to GSK's existing twice-daily drug Advair in one trial for chronic lung disease, but not another. That patchy record echoes results of other studies in an extensive development program. Britain's biggest drugmaker, howeveView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 1:23 pm By:

Lung_Breathing Lungs and Breathing OW Health

GSK lung drug has mixed results but filing on track: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to sub... http://t.co/W4eIxzVS

2 months ago...

GSK lung drug has mixed results but filing on track - Yahoo! News

news.yahoo.com — “From Yahoo! News: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday. The new once-a-day inhaled medicine showed superiority to GSK's existing twice-daily drug Advair in one trial for chronic lung disease, but not another. That patchy record echoes results of other studies in an extensive development program. Britain's biggest drugmaker, howeveView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 1:31 pm By:

HealthTrendster HealthTrendster Health Executive

GSK lung drug has mixed results but filing on track - LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit... http://t.co/pn6eaUBd

2 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390